-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting (Global page)
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
Improving continuum of care through digital therapeutics
May 13, 2022
In Asia Pacific (APAC), there is an increasing ageing population with more than 200 million people expected to move into aged 65 years and above. This represents a 71% increase in the number of elderly people between now and 20301. The ageing population tends to have a higher prevalence of chronic diseases and greater constraints on government spending is expected.
The situation is worsened by shortages in the healthcare workforce with the largest needs-based shortage of nurses occurring in Southeast Asia (SEA)2. Governments will try to minimize the impact on healthcare budgets by improving the cost effectiveness of treatments and focusing on preventive care.
Digital therapeutics (DTx) play a pivotal role in assisting healthcare providers deliver patient care outside of hospitals. DTx apps help to reduce re-admission rates and enable care providers to tailor services to each patient's specific needs and improve outcomes. They also make funding more flexible through bundling of services rather than funding by per hospital day or visit.
Continuing patient care outside of a hospital’s four walls
Let’s take the following hypothetical situation:
Consider a heart attack survivor who after being discharged from the hospital, is expected to continue the recovery at home. Returning home after a heart attack can be a frightening situation especially in comparison to the close monitoring and safety they may have felt at the hospital. To manage recovery, they are often scheduled for frequent follow ups which entail travel, expenses, waiting times and care management in between visits.
Imagine how a patient could incorporate digital monitoring into the recovery plan:
Figure 1: Enhanced patient journey assisted by Digital therapeutics (DTx)
With digital therapeutics, healthcare professionals (HCPs) can monitor patients in real time beyond healthcare facility settings and provide digital triage and/or telephone triage to support patients in taking control of their health.
DTx also provides voluminous amounts of data. This real-world evidence contributes greatly to studying the efficacy of interventions, population health trends, and even establishing the value of the digital therapeutic itself.
Early potential indications for digital companion therapies are primarily in chronic disease management which include (non-exhaustive):
Chronic care models for the future
To create a closed loop strategy for patient care outside of hospitals, all stakeholders are encouraged to work closely with each other:
Figure 2: Stakeholder collaboration across the healthcare ecosystem
Some developed countries like US, Europe and Australia have implemented ‘home hospital’ models, which seek to address the shortage of hospital beds and high operational costs by providing inpatient care at home with comparable clinical outcomes. These services include regular visits by doctors, nurses and allied health professionals in addition to utilizing digital tools such as remote monitoring and telecommunication technologies. In SEA, Singapore was the first country to launch the ‘home hospital’ trial in 2021 and the study is expected to complete by the end of 2022.
With a plethora of new tools, healthcare delivery will continue to evolve at an accelerated pace and good planning and governance are key in making sure that resources, investments, and systems are in the right place.
For more information on the continuum of patient care and digital therapeutics, please feel free to contact us.
References
1 Advancing into the Golden Years. Marsh & McLennan Companies’ Asia Pacific Risk Center (APRC).
2 State of the world’s nursing 2020 report. World Health Organization.